Richard Sutton, MD, PhD
Biography
Richard Sutton, MD, PhD, specializes in infectious diseases and microbial pathogenesis, focusing on novel HIV therapeutics and cure efforts. He is the chief of infectious diseases at VA Connecticut Healthcare, where he attends on both the infectious diseases and internal medicine services.
Dr. Sutton decided to train in infectious diseases since it was very clear that HIV was going to be critically important for many decades. "To support medicine and science trainees and to hear about their exciting news is truly the favorite part of my job." he says.
Dr. Sutton's research program studies the development of innovative therapeutics against HIV Rev and Tat, two essential regulatory proteins of the virus. He is also investigating transcriptional and post-transcriptional control of CCR5, which is the co-receptor required for R5-tropic HIV entry into cells.
A 2013 Avant Garde Scholar, Edward Mallinckrodt Jr. Foundation Scholar, and recipient of the Pfizer Postdoctoral Scholar Award, Dr. Sutton’s research has been funded by ViiV Healthcare, the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, and the American Heart Association, among others.
Dr. Sutton is a professor of medicine at Yale School of Medicine.
Titles
- Professor of Medicine (Infectious Diseases) and of Microbial Pathogenesis; Chief, Infectious Diseases Research at VACT
Education & Training
- Post-doctoral fellowUCSF then Stanford University (1998)
- FellowUC San Francisco (1993)
- ResidentHospital University of Pennsylvania (1992)
- PhDStanford University School of Medicine (1989)
- MDStanford University School of Medicine (1989)
Additional Information
Biography
Richard Sutton, MD, PhD, specializes in infectious diseases and microbial pathogenesis, focusing on novel HIV therapeutics and cure efforts. He is the chief of infectious diseases at VA Connecticut Healthcare, where he attends on both the infectious diseases and internal medicine services.
Dr. Sutton decided to train in infectious diseases since it was very clear that HIV was going to be critically important for many decades. "To support medicine and science trainees and to hear about their exciting news is truly the favorite part of my job." he says.
Dr. Sutton's research program studies the development of innovative therapeutics against HIV Rev and Tat, two essential regulatory proteins of the virus. He is also investigating transcriptional and post-transcriptional control of CCR5, which is the co-receptor required for R5-tropic HIV entry into cells.
A 2013 Avant Garde Scholar, Edward Mallinckrodt Jr. Foundation Scholar, and recipient of the Pfizer Postdoctoral Scholar Award, Dr. Sutton’s research has been funded by ViiV Healthcare, the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, and the American Heart Association, among others.
Dr. Sutton is a professor of medicine at Yale School of Medicine.
Titles
- Professor of Medicine (Infectious Diseases) and of Microbial Pathogenesis; Chief, Infectious Diseases Research at VACT
Education & Training
- Post-doctoral fellowUCSF then Stanford University (1998)
- FellowUC San Francisco (1993)
- ResidentHospital University of Pennsylvania (1992)
- PhDStanford University School of Medicine (1989)
- MDStanford University School of Medicine (1989)